Cargando…

Adding Cyclooxygenase Inhibitors to Immune Checkpoint Inhibitors Did Not Improve Outcomes in Metastatic Renal Cell Carcinoma

Modulating the cyclooxygenase 2 (COX-2) pathway has improved responses to immune checkpoint inhibitors (ICIs) in certain solid tumors, such as melanoma. Little is known about COX-2 inhibition in response to ICIs in metastatic renal cell carcinoma (mRCC). In this retrospective cohort study, we examin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yumeng, Kumar, Premsai, Adashek, Jacob J., Skelton, William P., Li, Jiannong, Vosoughi, Aram, Chahoud, Jad, Manley, Brandon J., Spiess, Philippe E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406439/ https://www.ncbi.nlm.nih.gov/pubmed/36010582 http://dx.doi.org/10.3390/cells11162505

Ejemplares similares

Dissecting Outcomes: Should Cytoreductive Nephrectomy Be Performed for Patients With Metastatic Renal Cell Carcinoma With Sarcomatoid Dedifferentiation?
por: Adashek, Jacob J., et al.
Publicado: (2021)

Revisiting mechanisms of resistance to immunotherapies in metastatic clear-cell renal-cell carcinoma
por: Chatwal, Monica Sheila, et al.
Publicado: (2023)

Hyperprogression and Immune Checkpoint Inhibitors: Hype or Progress?
por: Adashek, Jacob J., et al.
Publicado: (2019)

Case Report: Two Cases of Chemotherapy Refractory Metastatic Penile Squamous Cell Carcinoma With Extreme Durable Response to Pembrolizumab
por: Chahoud, Jad, et al.
Publicado: (2020)

Clinical Development of PARP Inhibitors in Treating Metastatic Castration-Resistant Prostate Cancer
por: Adashek, Jacob J., et al.
Publicado: (2019)

Cannabinoid system and cyclooxygenases inhibitors
por: Păunescu, H, et al.
Publicado: (2011)

An update on treatment of penile cancer
por: Chadha, Juskaran, et al.
Publicado: (2022)

Concomitant Radioembolization and Immune Checkpoint Inhibition in Metastatic Renal Cell Carcinoma
por: Adashek, Jacob J., et al.
Publicado: (2018)

Cyclooxygenase-2 inhibitors: promise or peril?
por: Mengle-Gaw, Laurel J, et al.
Publicado: (2002)

Cyclooxygenase (COX) Inhibitors and the Newborn Kidney
por: Smith, Francine G., et al.
Publicado: (2012)

Colorectal Carcinoma, Cyclooxygenases, and COX Inhibitors
por: Ganduri, Vinutna, et al.
Publicado: (2022)

Real-World Survival Outcomes Associated With First-Line Immunotherapy, Targeted Therapy, and Combination Therapy for Metastatic Clear Cell Renal Cell Carcinoma
por: Chakiryan, Nicholas H., et al.
Publicado: (2021)

Zanzalintinib in combination with immune checkpoint inhibitors: Design of the renal cell carcinoma expansion stage cohorts in STELLAR-002
por: Motzer, Robert J, et al.
Publicado: (2023)

Antimetastatic activity of a cyclooxygenase-2 inhibitor
por: Roche-Nagle, G, et al.
Publicado: (2004)

Risk of Cardiovascular Events and Cyclooxygenase-2 Inhibitors
por: Tabrizchi, Reza
Publicado: (2006)

Celecoxib: a selective cyclooxygenase-2 inhibitor
por: Gandelman, M
Publicado: (2003)

Effects of Cyclooxygenase Inhibitors on Apoptotic Neuroretinal Cells
por: Brust, Anja-Kristina, et al.
Publicado: (2008)

Renal Effects of Prostaglandins and Cyclooxygenase-2 Inhibitors
por: Kim, Gheun-Ho
Publicado: (2008)

Antiproliferative Benzoindazolequinones as Potential Cyclooxygenase-2 Inhibitors
por: Molinari, Aurora, et al.
Publicado: (2019)

Combined Effects of Cyclooxygenase-1 and Cyclooxygenase-2 Selective Inhibitors on Ovarian Carcinoma in Vivo
por: Li, Wei, et al.
Publicado: (2011)

Case Report of AdAPT-001-Mediated Sensitization to a Previously Failed Checkpoint Inhibitor in a Metastatic Chordoma Patient
por: Kesari, Santosh, et al.
Publicado: (2023)

Tolerance of neurite outgrowth to Rho kinase inhibitors decreased by cyclooxygenase-2 inhibitor☆
por: Duan, Weigang, et al.
Publicado: (2012)

Cyclooxygenase-1-selective inhibitor SC-560
por: Long, Sihui, et al.
Publicado: (2009)

Stimulatory Action of Cyclooxygenase Inhibitors on Hematopoiesis: A Review
por: Hofer, Michal, et al.
Publicado: (2012)

In situ click chemistry generation of cyclooxygenase-2 inhibitors
por: Bhardwaj, Atul, et al.
Publicado: (2017)

Biomarkers of the Response to Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma
por: Chen, Siteng, et al.
Publicado: (2020)

Predictive Biomarkers for Immune Checkpoint Inhibitors in Metastatic Breast Cancer
por: Sivapiragasam, Abirami, et al.
Publicado: (2020)

Checkpoint inhibitor therapy for metastatic triple-negative breast cancer
por: Heeke, Arielle L., et al.
Publicado: (2021)

Checkpoint Inhibitors Immunotherapy in Metastatic Melanoma: When to Stop Treatment?
por: De Risi, Ivana, et al.
Publicado: (2022)

Immune checkpoint inhibitors in advanced and recurrent/metastatic cervical cancer
por: Han, Xiling, et al.
Publicado: (2022)

Immune checkpoint inhibitors for unresectable or metastatic pleomorphic dermal sarcomas
por: Helbig, Doris, et al.
Publicado: (2022)

Cardiovascular Immunotoxicity Associated with Immune Checkpoint Inhibitors in Metastatic Melanoma
por: L’Orphelin, Jean-Matthieu, et al.
Publicado: (2023)

Fueling the engine and releasing the break: combinational therapy of cancer vaccines and immune checkpoint inhibitors
por: Kleponis, Jennifer, et al.
Publicado: (2015)

The Immune Microenvironment in Penile Cancer and Rationale for Immunotherapy
por: Ahmed, Mohamed E., et al.
Publicado: (2020)

Importance of adherence to gastroprotection during cyclooxygenase 2 inhibitor treatment
por: Gargallo, Carla J., et al.
Publicado: (2013)

Prediction of the potency of mammalian cyclooxygenase inhibitors with ensemble proteochemometric modeling
por: Cortes-Ciriano, Isidro, et al.
Publicado: (2015)

Biological Evaluation and Docking Analysis of Daturaolone as Potential Cyclooxygenase Inhibitor
por: Rauf, Abdur, et al.
Publicado: (2016)

Mimosine Dipeptide Enantiomsers: Improved Inhibitors against Melanogenesis and Cyclooxygenase
por: Nguyen, Binh Cao Quan, et al.
Publicado: (2015)

Combining checkpoint inhibitors and BRAF-targeted agents against metastatic melanoma
por: Cooper, Zachary A., et al.
Publicado: (2013)

Combining targeted therapy and immune checkpoint inhibitors in the treatment of metastatic melanoma
por: Kim, Teresa, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_4nm5e4knsvbkp6bdl4npv0a8gi